Analyst Ratings for Merrimack Pharmaceuticals (MACK)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/25/2018 | JPMorgan | N/A | Downgrade | Underweight (Neutral) |
6.00 (14.00) |
12.07 (14.71) |
21.87% | Details |
| 8/5/2016 | TD Cowen | N/A | Downgrade | (Buy) |
N/A (N/A) |
5.92 (14.71) |
148.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
